Tabla de Contenidos: “…9.5 Gut Microbiota as Therapeutic Strategies for Cardiovascular Disease -- 9.5.1 Probiotics -- 9.5.2 Fecal Microbiota Transplantation -- References -- 10 Gut Microbiota and Inflammatory Bowel Diseases -- 10.1 Introduction -- 10.2 Intestinal Microbiome in IBD Patients -- 10.2.1 Dysbiosis in IBD -- 10.2.2 Genetic Factors of the Host Affecting the Pathogenesis of IBD -- 10.2.3 Environmental Factors in the Disruption of Gut Microbiota and Development of IBD -- 10.3 Interventions for the Treatment of IBD -- 10.3.1 Microbiome-modulating Approach in the Treatment of IBD -- 10.4 Conclusion -- References -- 11 Gut Microbiota and Diabetes -- 11.1 Introduction -- 11.2 Gut Microbiota -- 11.3 Role of Gut Microbiota in Diabetes -- 11.4 Alteration in Gut Microbiota Composition in T1 and T2 Diabetes -- 11.4.1 T1D -- 11.4.2 Type 2 Diabetes -- 11.5 Diabetic Complications -- 11.5.1 Diabetic Retinopathy -- 11.5.2 Diabetic Nephropathy -- 11.5.3 Diabetic Neuropathy -- 11.6 Therapeutic Approaches -- 11.7 Conclusion -- References -- 12 Novel Therapeutic Strategies Targeting Gut Microbiota to Treat Diseases -- 12.1 Introduction -- 12.2 Changes in the Composition of the Gut Microbiota in Patients with T1D -- 12.3 The Potential Role of the Gut Microbiota in the Development of T1D -- 12.4 Changes in the Composition of the Gut Microbiota in Patients with T2D -- 12.5 The Potential Role of the Gut Microbiota in the Development of T2D -- 12.7 Preventive and Therapeutic Perspectives Including the Gut Microbiota -- References -- 13 Understanding the Role of Microbiota in Cancer -- 13.1 Introduction -- 13.2 Role of Microbiota in Cancers -- 13.2.1 Gastric Cancer -- 13.2.2 Colorectal Cancer -- 13.2.3 Liver Cancer -- 13.2.4 Pancreatic Cancer -- 13.3 Mechanism in which Microbiota Kill Cancer Cells -- 13.4 Microbiota that Promote Health Post Cancer Treatment -- 13.5 Conclusion…”

Tabla de Contenidos: “…Chapter 2: Build a Breast Cancer Prognosis Pipeline with the Power of Spark and Scala -- Breast cancer classification problem -- Breast cancer dataset at a glance -- Logistic regression algorithm -- Salient characteristics of LR -- Binary logistic regression assumptions -- A fictitious dataset and LR -- LR as opposed to linear regression -- Formulation of a linear regression classification model -- Logit function as a mathematical equation -- LR function -- Getting started -- Setting up prerequisite software -- Implementation objectives -- Implementation objective 1 - getting the breast cancer dataset -- Implementation objective 2 - deriving a dataframe for EDA -- Step 1 - conducting preliminary EDA -- Step 2 - loading data and converting it to an RDD[String] -- Step 3 - splitting the resilient distributed dataset and reorganizing individual rows into an array -- Step 4 - purging the dataset of rows containing question mark characters -- Step 5 - running a count after purging the dataset of rows with questionable characters -- Step 6 - getting rid of header -- Step 7 - creating a two-column DataFrame -- Step 8 - creating the final DataFrame -- Random Forest breast cancer pipeline -- Step 1 - creating an RDD and preprocessing the data -- Step 2 - creating training and test data -- Step 3 - training the Random Forest classifier -- Step 4 - applying the classifier to the test data -- Step 5 - evaluating the classifier -- Step 6 - running the pipeline as an SBT application -- Step 7 - packaging the application -- Step 8 - deploying the pipeline app into Spark local -- LR breast cancer pipeline -- Implementation objectives -- Implementation objectives 1 and 2 -- Implementation objective 3 - Spark ML workflow for the breast cancer classification task -- Implementation objective 4 - coding steps for building the indexer and logit machine learning model…”

Tabla de Contenidos: “…General introduction about cancer -- 1.2. Cancer management -- 1.3. Role of nanomaterial ́s to combat cancer -- 2. …”

Tabla de Contenidos: “…Actividad física, longevidad y calidad de vida4. Cáncer y actividad física; 4.1. Cáncer colorrectal; 4.2. …”

Tabla de Contenidos:

Tabla de Contenidos: “…-- 5.3 Introduction to Machine Learning: Algorithms and Applications -- 5.4 Natural Language Processing -- 5.5 The Internet of Things -- 5.6 Prospective AI Advantages in Orthopedics -- 5.7 Diagnostic Application of AI -- 5.8 Prediction Application With AI -- 5.9 Conclusion -- 6 Significance of Artificial Intelligence in Spinal Disorder Treatment -- 6.1 Introduction -- 6.2 Machine Learning -- 6.3 Methods Derived From Statistics -- 6.4 Applications of Machine Learning in Spine Surgery -- 6.5 Application of AI and ML in Spine Research -- 6.6 Conclusion -- 7 Osteoporosis Biomarker Identification and Use of Machine Learning in Osteoporosis Treatment -- 7.1 Introduction -- 7.2 Biomarkers of Bone Development -- 7.3 Biomarkers for Bone Resorption -- 7.4 Regulators of Bone Turnover -- 7.5 Methods to Identify Osteoporosis -- 7.6 Conclusion -- 8 The Role of AI in Pediatric Orthopedics -- 8.1 Introduction -- 8.2 Strategy Based on Artificial Intelligence -- 8.3 Several Applications of Artificial Intelligence -- 8.4 Conclusion -- 9 Use of Artificial Intelligence in Imaging for Bone Cancer -- 9.1 Introduction -- 9.2 Applications of Machine Learning to Cancer Diagnosis -- 9.3 Artificial Intelligence Methods for Diagnosing Bone Cancer -- 9.4 Methodologies for Constructing Deep Learning Model -- 9.5 Clinical Image Applications of Deep Learning for Bone Tumors -- 9.6 Conclusion -- References -- Index…”

Tabla de Contenidos: “…Results in melanoma patients treated for residual disease / Influence of BCG immunotherapy on circulating lymphoid populations of cancer patients. II. Results in breast cancer patients treated for residual disease / Histogram of regional lymph nodes in tumors of the ear, nose and throat (ENT) / Cell electrophoretic characterization of lymphocytes from patients with treated and untreated sarcoidosis / Cell electrophoretic studies on lymphocytes after transplantation / Further studies on the influence of the method of isolation of human peripheral blood lymphocytes on the distribution of their electrophoretic mobilities / Characterization of electrophoretically separated lymphocytes subpopulations in human peripheral blood…”

Tabla de Contenidos: “…Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders.5050 Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders -- Chapter 73: Disorders Associated with Intellectual Disabilities -- Section 8: Endocrinologic Disorders -- Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid Disorders -- Chapter 76: Adrenal Gland Disorders -- Chapter e77: Pituitary Gland Disorders -- Section 9: Gynecologic and Obstetric Disorders -- Chapter 78: Pregnancy and Lactation: Therapeutic Considerations -- Chapter 79: Contraception -- Chapter 80: Menstruation-Related Disorders -- Chapter 81: Endometriosis -- Chapter 82: Hormone Therapy in Women -- Section 10: Urologic Disorders -- Chapter 83: Erectile Dysfunction -- Chapter 84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary Incontinence -- Section 11: Immunologic Disorders -- Chapter e86: Function and Evaluation of the Immune System -- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88: Drug Allergy -- Chapter 89: Solid-Organ Transplantation -- Section 12: Rheumatologic Disorders -- Chapter 90: Osteoarthritis -- Chapter 91: Rheumatoid Arthritis -- Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93: Gout and Hyperuricemia -- Section 13: Ophthalmic and Otolaryngological Disorders -- Chapter 94: Glaucoma -- Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97: Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions -- Section 15: Hematologic Disorders -- Chapter 100: Anemias -- Chapter 101: Coagulation Disorders -- Chapter 102: Sickle Cell Disease -- Chapter e103: Drug-Induced Hematologic Disorders -- Section 16: Infectious Diseases -- Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy -- Chapter 105: Antimicrobial Regimen Selection -- Chapter 106: Central Nervous System Infections -- Chapter 107: Lower Respiratory Tract Infections -- Chapter 108: Upper Respiratory Tract Infections -- Chapter 109: Influenza -- Chapter 110: Skin and Soft-Tissue Infections -- Chapter 111: Infective Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings -- Chapter 114: Intra-Abdominal Infections -- Chapter 116: Urinary Tract Infections and Prostatitis -- Chapter e115: Parasitic Diseases -- Chapter 117: Sexually Transmitted Diseases -- Chapter 118: Bone and Joint Infections -- Chapter 119: Sepsis and Septic Shock -- Chapter 120: Superficial Fungal Infections -- Chapter 121: Invasive Fungal Infections -- Chapter 122: Infections in Immunocompromised Patients -- Chapter 123: Antimicrobial Prophylaxis in Surgery -- Chapter e124: Travel Health -- Chapter 125: Vaccines and Immunoglobulins -- Chapter 126: Human Immunodeficiency Virus Infection -- Section 17: Oncologic Disorders -- Chapter 127: Cancer Treatment and Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129: Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter 131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter 133: Ovarian Cancer -- Chapter 134: Acute Leukemias -- Chapter 135: Chronic Leukemias -- Chapter 136: Multiple Myeloma -- Chapter e137: Myelodysplastic Syndromes -- Chapter e138: Renal Cell Carcinoma -- Chapter 139: Melanoma -- Chapter 140: Hematopoietic Stem Cell Transplantation -- Section 18: Nutritional Disorders -- Chapter 141: Assessment of Nutrition Status and Nutrition Requirements -- Chapter 142: Parenteral Nutrition -- Chapter 143: Enteral Nutrition -- Chapter 144: Obesity…”

“…El colectivo que nos ocupa consta de personas que, tras haber sufrido un cáncer de laringe, les han extirpado las cuerdas vocales y no pueden hablar con voz laringada y tienen que aprender a hablar con la llamada voz esofágica…”

“…Angiogenesis is relevant to medicine, engineering, pharmacology, and pathology and to the many patients suffering from blood vessel diseases and cancer, among others. We are hoping that this book will become a source of inspiration and novel ideas for all…”

“…Furthermore, aberrant protein phosphorylation is implicated in the onset and progression of human diseases such as cancer and neurodegenerative disorders. In the last years, tens of thousands of in vivo phosphorylation events have been identified by large-scale quantitative phospho-proteomics experiment suggesting that a large fraction of the proteome might be regulated by phosphorylation. …”

“…The chapters include information on physiological and pathological conditions such as alteration in testosterone production by Leydig cells, prostate cancer, and metabolic disorders. Moreover, this book refers to the potential use of androgens in assisted human reproduction treatments and bovine breeding. …”

“…Rigorous and careful biochemical studies ranging from in-vitro experiments on a plethora of human-cancer derived cell lines to in-vivo and ex-vivo studies allowed the authors to identify the molecular targets and gain useful information on structure–activity relationships (SAR). …”

“…It extends a previous analysis (Van Doorslaer and Masseria, 2004) to 2008-2009 for 13 countries, and adds new results for 6 countries, for doctor and dentist visits, and cancer screening. Quintile distributions and concentration indices were used to assess inequalities. …”

“…It includes different kinds of chapters for clinical physical therapy with precious points for physical therapy, physical therapy for cancer, chronic venous disease, mental health, and other topics. …”

“…"Author Kathlyn Conway, a three-time cancer survivor, believes that the triumphalist approach to writing about illness fails to do justice to the shattering experience of disease. …”

“…Specialists of this discipline treat patients with impacted teeth, facial pain, misaligned jaws, facial trauma, oral cancer, cysts and tumors; they also perform facial cosmetic surgery and place dental implants. …”